{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:37:55Z","timestamp":1788907075762,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Despite the higher burden of cervical cases, screening programs in highly affected developing countries remained low. This made the disease to be present at an advanced stage which is almost always fatal, causing enormous pain and suffering for the individual and having significant adverse effects on the welfare of their families and community. Thus, this study aimed to assess determinants of cervical cancer screening utilization among women attending health facilities in Dessie Town, Northeast Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An institution-based unmatched case\u2013control study design was employed on 430 women (146 cases and 284 controls) at selected health facilities of Dessie town, South Wollo Zone, from July 1\/2020 to August 30\/2020. Cases were selected for all women screened for cervical cancer during the data collection period until the required sample size was attained and using a consecutive sampling technique, every 3 participants from women who come for services other than cervical cancer screening. were included as controls. Pretested and structured questionnaires were used to collect the data. Data were analyzed by SPSS version 25 software. Bivariable and multivariable logistics regression analysis was done. An adjusted odds ratio with 95% CI was estimated to measure the strength of the association. The level of statistical significance was declared at a <jats:italic>p<\/jats:italic>-value\u2009&lt;\u20090.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Age group of 35 and more [AOR\u2009=\u200911.52(6.09\u201321.77)], being a private employee [AOR\u2009=\u20094.67(2.41\u20139.03)], having symptoms of vaginal bleeding or pelvic pain or postcoital bleeding or vaginal discharge [AOR\u2009=\u20093.08(1.37\u20136.95)], being recommended by a physician for screening [[AOR\u2009=\u20093.07(1.45\u20136.49)] and positive attitude towards cervical cancer screening [AOR\u2009=\u20095.3(2.8\u201310.59)] were determinants of cervical cancer screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Age group of 35 and more, current occupation as a private employee, having symptoms of cervical cancer, being recommended by a physician for screening, and positive attitude towards cervical cancer screening were determinants of cervical cancer screening utilization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10447-0","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:07:32Z","timestamp":1671512852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia"],"prefix":"10.1186","volume":"22","author":[{"given":"Tilahun","family":"Assefa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastewal","family":"Arefaynie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wondwosen","family":"Mebratu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsabeth","family":"Addisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnael","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"10447_CR1","volume-title":"Comprehensive Cervical Cancer Control","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Comprehensive Cervical Cancer Control. 2014."},{"key":"10447_CR2","volume-title":"programmatic cervical cancer prevention","author":"PD Blumenthal","year":"2016","unstructured":"Blumenthal PD, Gaffikin L. programmatic cervical cancer prevention. 2016."},{"key":"10447_CR3","unstructured":"Cervical Cancer Screening Guidelines for Average-Risk Women a: 2015"},{"key":"10447_CR4","unstructured":"World Health Organization. Cervical cancer screening in developing countries. Report of a WHO consultation. Geneva, WHO Press. 2009;34(4)."},{"key":"10447_CR5","doi-asserted-by":"crossref","unstructured":"The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia\u202f: Successes. 2016;4(1):87\u201398.","DOI":"10.9745\/GHSP-D-15-00325"},{"key":"10447_CR6","volume-title":"Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. 2015."},{"key":"10447_CR7","unstructured":"Global strategy toward eliminating cervical cancer as a public health problem. 2019;(December):1\u201333."},{"issue":"1","key":"10447_CR8","first-page":"1","volume":"5","author":"Z Gebru","year":"2016","unstructured":"Gebru Z, Gerbaba M, Dirar A. Journal of women\u2019s health care utilization of cervical carcinoma screening service and associated factors among currently married women in Arba Minch Town. Southern. 2016;5(1):1\u20134.","journal-title":"Southern"},{"key":"10447_CR9","unstructured":"Getachew E, Addisse A, Getachew S, Submitted T, Science H, Health P, et al. Knowledge Attitude and Practice on Cervical Cancer and Screening among Reproductive health Service Clients, Addis Ababa, Ethiopia, 2015"},{"key":"10447_CR10","doi-asserted-by":"crossref","unstructured":"Gebreegziabher M, Asefa NG, Berhe S. Factors Affecting the Practices of Cervical Cancer Screening among Female Nurses at Public Health Institutions in Mekelle Town, Northern Ethiopia, 2014\u202f: A Cross-Sectional Study. 2016","DOI":"10.1155\/2016\/4743075"},{"key":"10447_CR11","doi-asserted-by":"crossref","unstructured":"Mitiku I, Tefera F. Knowledge about Cervical Cancer and Associated Factors among 15\u201349-Year-Old Women in Dessie Town, Northeast Ethiopia. 2016;1\u201310.","DOI":"10.1371\/journal.pone.0163136"},{"key":"10447_CR12","unstructured":"FEDERAL MINISTRY OF HEALTH. Guideline for cervical cancer prevention and control in Ethiopia ;(October 2015)."},{"key":"10447_CR13","unstructured":"World Health Organization. Draft\u202f: Global Strategy Towards the Elimination of. 2019;1\u201324. https:\/\/www.who.int\/docs\/default-source\/documents\/cervical-cancer-elimination-draft-strategy.pdf?sfvrsn=380979d6_4. Available from:"},{"key":"10447_CR14","unstructured":"C CERVICAL C ANCER S SCREENING U . S . Department of Health and Human Services Health Resources and Services Administration."},{"key":"10447_CR15","unstructured":"Nene B, Jayant K, Arrossi S, Shastri S, Budukh A, Hingmire S. Determinants of women's participation in cervical cancer screening trial, Maharashtra, India. 2007;031195(April)."},{"key":"10447_CR16","doi-asserted-by":"crossref","unstructured":"Geremew AB, Gelagay AA, Azalea T. Uptake of pre-cervical cancer screening service and associated factors among women aged 30\u201349 years in Finote Selam town northwest Ethiopia. 2018;10(2):829\u201342.","DOI":"10.1186\/s12978-018-0471-1"},{"key":"10447_CR17","unstructured":"L Gebremariam T Kahsay K Berhe 2018 Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia Case-control study 2019 1 11"},{"key":"10447_CR18","unstructured":"Application Predictors Of Cervical Cancer Screening Practice Among Hiv-Positive Women Attending Adult Antiretroviral Clinics, Bishoftu, Ethiopia,2018;"},{"key":"10447_CR19","doi-asserted-by":"publisher","unstructured":"Ndejjo R, Mukama T, Musabyimana A, Musoke D. Uptake of Cervical Cancer Screening and Associated Factors among Women in Rural Uganda\u202f: A Cross-Sectional Study. 2016;(February). http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1371\/journal.pone.0149696. Available from","DOI":"10.1371\/journal.pone.0149696"},{"key":"10447_CR20","first-page":"1","volume":"2019","author":"SA Bante","year":"2017","unstructured":"Bante SA, Getie SA, Getu AA, Mulatu K. Uptake of pre-cervical cancer screening and associated factors among reproductive age women in Debre Markos town Northwest Ethiopia. BMC Public Health. 2017;2019:1\u20139.","journal-title":"BMC Public Health"},{"key":"10447_CR21","doi-asserted-by":"crossref","unstructured":"Idowu A, Olowookere SA, Fagbemi AT, Ogunlaja OA. Determinants of Cervical Cancer Screening Uptake among Women in Ilorin, North Central Nigeria\u202f: A Community-Based Study. 2016;2016(Vili). 016;17:3763\u20137.","DOI":"10.1155\/2016\/6469240"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10447-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:09:35Z","timestamp":1671512975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10447-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10447"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10447-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from a research review board of the College of Medicine and Health Sciences, Wollo University. After explaining the purpose of the study, written informed consent was obtained from participants before data collection. They were informed that participating in the study was voluntary and their right to withdraw from the study at any time during the interview was assured. For this purpose, a one-page consent letter was attached as a cover page of each questionnaire stating the general objective of the study and issues of confidentiality. All methods were performed under the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participants"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest related to authorship and financial issues.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1330"}}